Literature DB >> 10711428

Esophageal histology does not provide additional useful information over clinical assessment in identifying reflux patients presenting for esophagogastroduodenoscopy.

S Nandurkar1, N J Talley, C J Martin, T Ng, S Adams.   

Abstract

We prospectively evaluated the value of histology in identifying gastroesophageal reflux disease (GERD) in consecutive patients enrolled for upper endoscopy. GERD was defined as heartburn occurring at least weekly. Macroscopic esophagitis was graded and an esophageal biopsy was taken 2 cm above the gastroesophageal junction. Histological esophagitis was identified by: (1) basal cell hyperplasia >15%, (2) increased papillary length >66%, and (3) infiltration by leukocytes/eosinophils. The sensitivity, specificity, and positive and negative predictive value of histological esophagitis in patients with and without typical reflux symptoms, with and without endoscopic changes, or both were evaluated. Of 178 patients, reflux symptoms were present in 59% (N = 105) and esophageal erosions in 19% (N = 34); 75 patients had reflux symptoms but no erosions. While the specificity of histology was adequate (78%), it was insensitive (30%). The positive and negative predictive values were 67% and 44%, respectively. No single individual parameter was better than any other. Thus, histology appears to be of no additional value in identifying GERD.

Entities:  

Mesh:

Year:  2000        PMID: 10711428     DOI: 10.1023/a:1005449302408

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

1.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  The normal human esophageal mucosa: a histological reappraisal.

Authors:  W M Weinstein; E R Bogoch; K L Bowes
Journal:  Gastroenterology       Date:  1975-01       Impact factor: 22.682

Review 3.  Consensus Statement for Management of Gastroesophageal Reflux Disease: result of workshop meeting at Yale University School of Medicine, Department of Surgery, November 16 and 17, 1997.

Authors:  S F Moss; R Arnold; G N Tytgat; S J Spechler; G Delle-Fave; D Rosin; R T Jensen; I M Modlin
Journal:  J Clin Gastroenterol       Date:  1998-07       Impact factor: 3.062

4.  Esophageal histology in gastroesophageal reflux. Morphometric findings in suction biopsies.

Authors:  U Seefeld; G J Krejs; R E Siebenmann; A L Blum
Journal:  Am J Dig Dis       Date:  1977-11

5.  Histological consequences of gastroesophageal reflux in man.

Authors:  F Ismail-Beigi; P F Horton; C E Pope
Journal:  Gastroenterology       Date:  1970-02       Impact factor: 22.682

6.  Dilated intercellular spaces: a morphological feature of acid reflux--damaged human esophageal epithelium.

Authors:  N A Tobey; J L Carson; R A Alkiek; R C Orlando
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

7.  Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease.

Authors:  N E Schindlbeck; B Wiebecke; A G Klauser; W A Voderholzer; S A Müller-Lissner
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

8.  The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease.

Authors:  R Carlsson; J Dent; E Bolling-Sternevald; F Johnsson; O Junghard; K Lauritsen; S Riley; L Lundell
Journal:  Scand J Gastroenterol       Date:  1998-10       Impact factor: 2.423

9.  Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.

Authors:  T L Venables; R D Newland; A C Patel; J Hole; C Wilcock; M L Turbitt
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

10.  Is long-term esophageal pH monitoring of clinical value?

Authors:  A G Klauser; C Heinrich; N E Schindlbeck; S A Müller-Lissner
Journal:  Am J Gastroenterol       Date:  1989-04       Impact factor: 10.864

View more
  8 in total

Review 1.  Biopsy assessment of drug efficacy in the gastrointestinal tract.

Authors:  Marjorie M Walker
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

Review 2.  [Correct diagnosis for indication in gastroesophageal reflux disease].

Authors:  A H Hölscher; E Bollschweiler; Ch Gutschow; P Malfertheiner
Journal:  Chirurg       Date:  2005-04       Impact factor: 0.955

Review 3.  Minimal changes in reflux esophagitis: red ones and white ones.

Authors:  Michio Hongo
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

4.  Histological changes in the oesophageal squamous mucosa: correlation with ambulatory 24 hour pH monitoring.

Authors:  D J Bowrey; G T Williams; G W B Clark
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

5.  Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations.

Authors:  Luca Mastracci; Paola Spaggiari; Federica Grillo; Patrizia Zentilin; Pietro Dulbecco; Paola Ceppa; Paola Baccini; Carlo Mansi; Vincenzo Savarino; Roberto Fiocca
Journal:  Virchows Arch       Date:  2008-12-02       Impact factor: 4.064

Review 6.  Diagnostic options for patients with refractory GERD.

Authors:  Fernando Fornari; Daniel Sifrim
Journal:  Curr Gastroenterol Rep       Date:  2008-06

7.  Current trends in the management of gastroesophageal reflux disease: a review.

Authors:  Sylvester Chuks Nwokediuko
Journal:  ISRN Gastroenterol       Date:  2012-07-11

8.  Atypical symptoms in patients with gastroesophageal reflux disease.

Authors:  Chih-Hsun Yi; Tso-Tsai Liu; Chien-Lin Chen
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.